364 related articles for article (PubMed ID: 15555116)
1. Prevention of cardiovascular events in diabetes.
Malcolm J; Meggison H; Sigal R
Clin Evid; 2003 Dec; (10):690-714. PubMed ID: 15555116
[No Abstract] [Full Text] [Related]
2. Prevention of cardiovascular events in diabetes.
Sigal R; Malcolm J; Arnaout A
Clin Evid; 2006 Jun; (15):623-45. PubMed ID: 16973029
[No Abstract] [Full Text] [Related]
3. Prevention of cardiovascular events in diabetes.
Sigal R; Malcolm J; Meggison H
Clin Evid; 2004 Jun; (11):777-806. PubMed ID: 15652037
[No Abstract] [Full Text] [Related]
4. Secondary prevention of ischaemic cardiac events.
Gami A
Clin Evid; 2006 Jun; (15):195-228. PubMed ID: 16973010
[No Abstract] [Full Text] [Related]
5. Acute coronary syndrome: are intervention and IIb/IIIa platelet inhibitors epiphenomena?
Jackson G
Int J Clin Pract; 2001; 55(6):351-2. PubMed ID: 11501219
[No Abstract] [Full Text] [Related]
6. Should we prescribe statin and aspirin for every diabetic patient? Is it time for a polypill?
Wienbergen H; Senges J; Gitt AK
Diabetes Care; 2008 Feb; 31 Suppl 2():S222-5. PubMed ID: 18227489
[No Abstract] [Full Text] [Related]
7. Cardiovascular disease in diabetes.
Malcolm J; Meggison H; Sigal R
Clin Evid; 2002 Dec; (8):541-68. PubMed ID: 12603899
[No Abstract] [Full Text] [Related]
8. Cardiovascular disease in diabetes.
Sigal R; Malcolm J; Meggison H
Clin Evid; 2002 Jun; (7):498-520. PubMed ID: 12230676
[No Abstract] [Full Text] [Related]
9. Primary prevention of cardiovascular events and type 2 diabetes: should we prioritize our interventions?
Sultan A; Thuan JF; Avignon A
Diabetes Metab; 2006 Dec; 32(6):559-67. PubMed ID: 17296509
[TBL] [Abstract][Full Text] [Related]
10. Platelet function testing in cardiovascular diseases.
Michelson AD
Circulation; 2004 Nov; 110(19):e489-93. PubMed ID: 15533872
[No Abstract] [Full Text] [Related]
11. [Differentiated treatment of diabetics with an acute coronary syndrome].
Hamm CW; Hamann A
Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S208-10. PubMed ID: 17109250
[No Abstract] [Full Text] [Related]
12. [Old and new platelet aggregation inhibitors: which to choose for prevention of stroke?].
Devuyst G; Bogousslavsky J
Rev Med Suisse Romande; 2000 Sep; 120(9):697-702. PubMed ID: 11094533
[No Abstract] [Full Text] [Related]
13. Current antiplatelet therapies: benefits and limitations.
Angiolillo DJ; Guzman LA; Bass TA
Am Heart J; 2008 Aug; 156(2 Suppl):S3-9. PubMed ID: 18657680
[TBL] [Abstract][Full Text] [Related]
14. Perioperative management of antiplatelet agents in patients undergoing cardiac surgery.
Lavi S; Lavi R
J Cardiothorac Vasc Anesth; 2012 Aug; 26(4):680-6. PubMed ID: 22534412
[No Abstract] [Full Text] [Related]
15. [Antiplatelet agents--problem for cardiac surgeon].
Bochenek A; Wilczyński M
Kardiol Pol; 2006 Nov; 64(11):1329-31. PubMed ID: 17165174
[No Abstract] [Full Text] [Related]
16. Antiplatelet agents and arterial thrombosis.
Billett HH
Cardiol Clin; 2008 May; 26(2):189-201, vi. PubMed ID: 18406994
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet therapy in diabetes: efficacy and limitations of current treatment strategies and future directions.
Angiolillo DJ
Diabetes Care; 2009 Apr; 32(4):531-40. PubMed ID: 19336638
[No Abstract] [Full Text] [Related]
18. Canadian Hypertension Education Program. Brief overview of 2004 recommendations.
Campbell N;
Can Fam Physician; 2004 Oct; 50():1411-5. PubMed ID: 15526879
[No Abstract] [Full Text] [Related]
19. Percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients.
Mukherjee D
Cardiol Clin; 2005 May; 23(2):185-91. PubMed ID: 15694746
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological prevention of atherothrombotic events in patients with peripheral arterial disease.
Blinc A; Poredos P
Eur J Clin Invest; 2007 Mar; 37(3):157-64. PubMed ID: 17359482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
